MODIFIED C-LOOP, UV-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENSES

Intraocular Lens

FDA Premarket Approval P970034

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Indicated for the visual correction of aphakia in persons 60 years of age or older, who are undergoing extracapsular cataract extraction and primary lens implantation. The intraocular lens is intended to permanently replace the natural cataractous crystalline lens and to restore useful vision. It is intended for capsular bag placement only. The devices are available in a range of powers from 4 diopters (d) to 34d in 0. 5d increments.

DeviceMODIFIED C-LOOP, UV-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENSES
Classification NameIntraocular Lens
Generic NameIntraocular Lens
ApplicantAAREN SCIENTIFIC
Date Received1997-07-21
Decision Date1998-09-25
Notice Date1998-10-27
PMAP970034
SupplementS
Product CodeHQL
Docket Number98M-0855
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address AAREN SCIENTIFIC 4290 East Brickell St, Bldg A ontario, CA 91761

Supplemental Filings

Supplement NumberDateSupplement Type
P970034Original Filing
S014 2009-10-28 135 Review Track For 30-day Notice
S013
S012 2008-08-13 30-day Notice
S011 2008-08-13 30-day Notice
S010 2007-12-20 135 Review Track For 30-day Notice
S009 2001-04-19 Normal 180 Day Track
S008 2001-03-26 Normal 180 Day Track
S007 2000-07-06 Normal 180 Day Track
S006 2000-04-19 Normal 180 Day Track
S005 2000-02-14 Normal 180 Day Track
S004 2000-02-14 Panel Track
S003 1999-03-23 30-day Notice
S002 1998-12-21 Normal 180 Day Track
S001 1998-10-22 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.